id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1180717,3e9c6fa1-4713-4f9a-9e17-937c73497ce8,Q4,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2011,fourth_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,59600,0,0,2011-12-19T16:25:37-05:00
1180938,16b31231-4c17-4d4e-8a01-d09f22fbc1f9,Q4,RED+BLUE STRATEGIES,400693064,EXPRESS SCRIPTS INC.,2011,fourth_quarter,PHA,"H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies.

Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",30000,,0,0,2011-12-27T11:30:46-05:00
1180972,d0089a28-2a02-4cd2-bd37-4cc4b8382f87,Q4,RED+BLUE STRATEGIES,400693064,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2011,fourth_quarter,PHA,"H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2011-12-28T11:41:18-05:00
1181026,62f4a91d-fc26-43d1-9fcf-b4c32dc5f8b7,Q4,"R.G. FLIPPO AND ASSOCIATES, INC",14861,ALABAMA NURSING HOME ASSOCIATION,2011,fourth_quarter,PHA,S. 1560 Nursing Homes Resident Pain Relief Act-all provisions,"HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2011-12-29T15:08:50-05:00
1181029,a7dff21d-6582-4aa7-b991-fda885e5859d,Q4,RED+BLUE STRATEGIES,400693064,PEW CHARITABLE TRUSTS,2011,fourth_quarter,PHA,"H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act of 2011.  Supporting work to increase innovation and development of new antibiotics.
S. 1584 - Drug Safety and Accountability Act of 2011- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety.

Policies related to the growing concerns regarding drug shortage issues in hospitals across the country.","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",25000,,0,0,2011-12-29T16:55:51-05:00
1181058,366611e5-aea9-4ade-913c-8d048a177673,Q4,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2011,fourth_quarter,PHA,"Food and Drug Safety Globalization Act
Monitoring Dorgan-Snowe Drug Reimportation from Canada
Monitoring Protect IP Act
Monitoring SOPA","HOUSE OF REPRESENTATIVES,SENATE",21000,,0,0,2012-01-01T10:58:33-05:00
1181232,981f0fdc-45a2-47d7-9015-9d4cefd98566,Q4,INJURED WORKERS PHARMACY,400765309,INJURED WORKERS PHARMACY,2011,fourth_quarter,PHA,Transparency of Pharmacy Benefit Managers(bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshore and Harbor Workers Amendment Act of 2011 sponsored by Sen. Isakson.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-01-03T11:09:19-05:00
1182242,aeddcfc6-144d-4d58-b0c6-6491cc21527f,Q4,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2011,fourth_quarter,PHA,"H.R. 2245, S. 296, ""Preserving Access to Life-Saving Medications Act,"" all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, ""The Drug Safety and Accountability Act,"" a bill to ensure drug supply safety and give FDA mandatory recall authority.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2012-01-06T14:56:12-05:00
1182816,23e4e766-4f2e-4774-8c4c-710ea13225d0,Q4,NOVO NORDISK INC.,284790,NOVO NORDISK INC.,2011,fourth_quarter,PHA,"P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office",,386000,0,0,2012-01-09T20:42:32-05:00
1182939,10ff6c19-ef99-42e4-898d-1cef736c096e,Q4,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2011,fourth_quarter,PHA,"General issues affecting the pharmaceutical industry and bioequivelence.
The Life Sciences Investment Act (S. 1410; H.R. 2632)","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-10T10:09:57-05:00
1182996,b3c50d45-23fd-4787-9cef-a7db39a4d676,Q4,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2011,fourth_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148).","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-10T11:24:26-05:00
1183315,e461f592-cd3c-468d-ba8f-5bbda81ce837,Q4,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2011,fourth_quarter,PHA,"Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine.  In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",,120000,0,0,2012-01-10T17:05:23-05:00
1183453,7603c216-f2e3-435f-a7aa-72d74cc5afab,Q4,UPS (UNITED PARCEL SERVICE),39223,UPS (UNITED PARCEL SERVICE),2011,fourth_quarter,PHA,"-  S.1584/HR 3026 ""Safeguarding Americas Pharmaceuticals Act of 2011""; all issues relating to 3rd party logistics
- FDA Track and Trace
- Supply Chain Safety (Serialization v. Pedigree)   
- Pre-emption of individual State mandates to harness uniform technology","Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office",,1046921,0,0,2012-01-11T10:50:34-05:00
1183628,cc88e9ba-1400-4322-8307-b81c68f3fc3d,Q4,LONG TERM CARE PHARMACY ALLIANCE,400309443,LONG TERM CARE PHARMACY ALLIANCE,2011,fourth_quarter,PHA,Medicare Part D,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,201000,0,0,2012-01-11T14:41:57-05:00
1183665,46d7b187-a427-44d5-8b15-8b01393c8be5,Q4,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,GENENTECH,2011,fourth_quarter,PHA,Monitor Drug Safety and pedigree legislation.,"Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-11T14:57:07-05:00
1183686,22a047f6-5d58-4c5d-a630-f7102e1c3d1b,Q4,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,NOVO NORDISK,2011,fourth_quarter,PHA,"P.L. 111-148- Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152- The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-01-11T15:10:19-05:00
1183856,20b8f89e-c61f-4d40-b6a1-3913a00655d6,Q4,BUCHANAN INGERSOLL & ROONEY PC,55291,SHIRE PHARMACEUTICALS INC,2011,fourth_quarter,PHA,Life Sciences Investment Act; ESRD orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues; PDUFA; exclusivity periods,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-11T17:17:20-05:00
1184379,dfbf5179-85e9-42ce-9bd5-2ffa70cad98c,Q4,"SHELTER ROCK STRATEGIES, LLC",400772326,NEW YORK MEDICAL COLLEGE,2011,fourth_quarter,PHA,"BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Developement and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-12T14:55:34-05:00
1184905,8eb06651-56a3-4ba8-9afe-44ee2588de36,Q4,THE MATHIS HARPLE GROUP,322911,"EXPRESS SCRIPTS, INC",2011,fourth_quarter,PHA,Express Scripts / Medco Merger,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-01-13T10:50:17-05:00
1184944,7521eaa2-b58b-410e-92b4-9e61c8c62ec7,Q4,THE MATHIS HARPLE GROUP,322911,PILMA,2011,fourth_quarter,PHA,"Biologics, Rogue Sites","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-13T11:16:34-05:00
1185200,6d36a7fd-6527-411d-973d-5d4d77fe3f9a,Q4,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2011,fourth_quarter,PHA,"CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation.
S. 274 The Medication Management Empowerment Act of 2011. All provisions
S. 1002 Prohibit Theft of Medical Products 2011. All provisions.
Potential prescription drug track-and-trace legislation. CMS Medicare Part B diabetic supply audits Region D. Concerns with scope and requirements of audit.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2012-01-13T13:51:24-05:00
1185330,fbfd9d34-bfe8-4d8f-9d99-c718ffadf519,Q4,"NAHIGIAN STRATEGIES, LLC",322897,TEVA PHARMACEUTICALS USA INC,2011,fourth_quarter,PHA,Brand and generic pharmaceuticals,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-13T14:39:19-05:00
1185345,9fa909b2-7292-48d0-b437-80a193b6b0c6,Q4,"NAHIGIAN STRATEGIES, LLC",322897,TEVA PHARMACEUTICALS USA INC,2011,fourth_quarter,PHA,Brand and generic pharmaceutical issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-13T14:48:12-05:00
1185715,630b5c69-ee70-4b77-a97a-05a62558282c,Q4,"HEARTLAND SOLUTIONS GROUP, INC.",312133,ZEBRA TECHNOLOGIES CORPORATION,2011,fourth_quarter,PHA,"Any and all issues related to barcode, secure identification and real-time location systems.","Army, Dept of (Other),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-13T18:31:05-05:00
1185804,cb684482-c636-4981-aa1e-082b63380bcf,Q4,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2011,fourth_quarter,PHA,Issues related to drug shortages. S.296 Preserving Access to Life Saving Medications Act.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-01-14T11:02:43-05:00
1185810,7f8e539c-67ef-4a98-893b-03d53ea75b86,Q4,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,THE HEMOPHILIA ALLIANCE,2011,fourth_quarter,PHA,Issues realted to the 340B drug discount program.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-14T11:13:46-05:00
1185814,a95858aa-f6cb-4383-ac0b-6cdfc8fca488,Q4,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2011,fourth_quarter,PHA,"Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2012-01-14T11:15:48-05:00
1186047,b3e09afd-4cef-4769-a17d-9ed815b639ba,Q4,THORN RUN PARTNERS,400534596,LONG TERM CARE PHARMACY ALLIANCE,2011,fourth_quarter,PHA,"S.1560, Nursing Home Resident Pain Relief Act of 2011; Issues related to the implementation of the Affordable Care Act (ACA) and DEA enforcement of controlled substances in nursing homes.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-15T15:18:48-05:00
1186303,8d73cc4e-5683-4156-8e2d-61d0742d8d78,Q4,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2011,fourth_quarter,PHA,"Antibiotics in animal foods
Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-16T11:27:25-05:00
1186653,3efcbba8-4b22-4374-8f7b-a6a0375b959b,Q4,"EXPRESS SCRIPTS, INC.",294416,"EXPRESS SCRIPTS, INC.",2011,fourth_quarter,PHA,"Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058).","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,U.S. Trade Representative (USTR),White House Office",,370000,0,0,2012-01-16T14:48:44-05:00
1186999,9ac8e10b-29c7-470f-9fef-b74b7df168a7,Q4,SQUIRE PATTON BOGGS,30906,RANBAXY INC.,2011,fourth_quarter,PHA,"S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; S. 23/H.R. 1249 the America Invents Act; H.R. 2112, Agriculture, Rural Development, Food & Drug Administration, and Related Agencies Appropriations Act of 2012; H.R. 2055, the Consolidated Apppropriations Act of 2012; H.R. 3765, the Temporary Payroll Tax Cut Contribution Act.","HOUSE OF REPRESENTATIVES,SENATE",180000,,0,0,2012-01-17T08:57:24-05:00
1187422,ca6fb227-a478-4adc-a227-e12a3022de1f,Q4,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2011,fourth_quarter,PHA,"Importation of Preseciption Drugs (S.319, H.R. 147); Rx Pedigree (H.R. 3026); NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Import Safety (S. 1584)","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,280000,0,0,2012-01-17T11:42:25-05:00
1187873,788c1432-8c96-4059-a52e-96a42b64eba6,Q4,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2011,fourth_quarter,PHA,"Controlled Drug Substances Act (21 USC 13)
Stop Oxy Abuse Act (H.R. 1316)","HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2012-01-17T13:43:40-05:00
1189008,de37215e-154a-489f-9d51-61d46f3d36c3,4@,HAAKE & ASSOCIATES,17226,CRUCELL SWITZERLAND AG,2011,fourth_quarter,PHA,Work on policy and procurement matters related to vaccines,"Defense, Dept of (DOD),Defense Logistics Agency,HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID)",20000,,0,1,2012-01-17T18:09:55-05:00
1189127,233c23b9-5c01-42e4-a459-b1856f3de549,Q4,"RUBICON ADVISORS, LLC",315091,"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.",2011,fourth_quarter,PHA,"Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 14328 .316
Affordable Healthcare Choices Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-17T20:57:56-05:00
1189129,fbece14b-c4e3-4d06-b93d-2d96ed34f5b6,Q4,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2011,fourth_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969","HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2012-01-17T20:59:57-05:00
1189130,bb2093a9-4a69-478e-bb3b-9929c2e7fb83,Q4,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2011,fourth_quarter,PHA,"Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100
Affodable Health Choices Act","HOUSE OF REPRESENTATIVES,SENATE",105000,,0,0,2012-01-17T21:00:58-05:00
1189132,a86f62c3-4161-4a61-8718-598ca976b04b,Q4,"RUBICON ADVISORS, LLC",315091,WATSON PHARMACEUTICALS INC,2011,fourth_quarter,PHA,"Patent Reform H.R. 1908, Import Safety Act H.R. 2100     Affordable Health Choices Act
Patent Settlements H.R. 1432 S 316
Generic Biologics S 1685 H.R. 5629
Physician Payment Sunshine Act S 2029","HOUSE OF REPRESENTATIVES,SENATE",98000,,0,0,2012-01-17T21:01:59-05:00
1189598,b476da5c-8124-4f0f-a39a-88b89b940420,Q4,APOTEX CORP.,310973,APOTEX CORP.,2011,fourth_quarter,PHA,"S. 27, the Preserve Access to Affordable Pharmaceuticals Act
S. 1882, the FAIR Generics Act
S. 296, HR 2245, The Preserving Access to Life Savings Medications Act Amending Section 505(j) of the Food, Drug, and Cosmetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclams seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications

Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Caraco Pharmaceutical Laboratories Ltd. and Sub Pharmaceuticals Industries, Ltd.

Prospective action on legislation establishing a generic drug user fee program

Prospective action on legislation establishing a biosimilar user fee program

Establishment of a federal track and trace system for pharmaceuticals

Importation of prescription narcotic products into the United States

The use of Risk Evaluation Mitigation Strategies (REMS) programs by brand drug companies to delay generic competition","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2012-01-18T09:54:02-05:00
1189650,28b3d7d9-272e-4f59-a301-5258afac51fb,Q4,POLICY ADVOCATES,72018,GLAXOSMITHKLINE,2011,fourth_quarter,PHA,"Patent Reform, Budget, Taxes","HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2012-01-18T10:09:24-05:00
1189852,22260afc-7b1c-48d7-9159-ce962f2cc02c,Q4,STRATEGIES 360,79175,MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES,2011,fourth_quarter,PHA,"Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars,","Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-18T10:44:35-05:00
1190197,a1bc5071-bce0-4c56-9d63-d2919cfbe89e,Q4,THE INGRAM GROUP LLC,400577737,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2011,fourth_quarter,PHA,"Issues related to pharmaceutical importation, H.R. 2112, The Consolidated and Further Continuing Appropriations Act of 2012.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-18T11:32:44-05:00
1190568,d26d183e-6ca8-48e9-a812-0f6e3b3f0286,Q4,AMERICAN VETERINARY MEDICAL ASSOCIATION,3630,AMERICAN VETERINARY MEDICAL ASSOCIATION,2011,fourth_quarter,PHA,"H.R. 965/S. 1211, Preservation of Antibiotics for Medical treatment Act
H.R. 1406 Fairness to Pet Owners Act
ADUFA and AGDUFA Reauthorization","Agriculture, Dept of (USDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,180000,0,0,2012-01-18T12:39:17-05:00
1190665,c5dfe2ea-512e-4754-893e-fc34754f32c0,Q4,"NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC",400689052,WOCKHARDT USA LLC,2011,fourth_quarter,PHA,Issues affecting preemption for generic labels,"HOUSE OF REPRESENTATIVES,SENATE",25000,,0,0,2012-01-18T12:54:52-05:00
1191167,deacd640-8797-4c16-a00e-a2f612f7bead,Q4,SHIRE PHARMACEUTICALS LLC,323477,SHIRE PHARMACEUTICALS LLC,2011,fourth_quarter,PHA,"S. 296, Preserving Access to Life Saving Medicines Act; H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act (ULTRA); Life Sciences Investment Act
Issues relating to R&D funding for rare disease products, biosimilars and other products; end stage renal disease (ESRD) orphan drugs; reimbursements; drug shortages; DEA quotas; prescription drug user fees; exclusivity periods","HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2012-01-18T14:22:18-05:00
1191492,e7ab47ff-d9bb-401e-aaf7-568dc1da4fbf,Q4,BUTLER SNOW LLP,400421012,ANAZAOHEALTH CORPORATION,2011,fourth_quarter,PHA,CMS Reimbursements,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-18T15:02:20-05:00
1191595,5276839b-6c37-4fbf-bed5-ffb325f2dce5,Q4,"VAN HEUVELEN STRATEGIES, LLC",321874,DAVITA,2011,fourth_quarter,PHA,"Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance.  Implementation of Patient Protection and Affordable Care Act. Implementation of the Budget Control Act. H.R. 3630, Temporary Payroll Tax Cut Continuation Act of 2011.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-18T15:20:04-05:00
1191604,333335b8-67b2-4ecc-9e0e-af61e74f7cd9,4A,"EXPRESS SCRIPTS, INC.",294416,"EXPRESS SCRIPTS, INC.",2011,fourth_quarter,PHA,"Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058).","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,U.S. Trade Representative (USTR),White House Office",,370000,0,0,2012-01-18T15:21:06-05:00
1191917,eba064a1-4bb1-4540-9796-fe9858b3f82c,Q4,EVERTZ GROUP LLC,400497446,MYLAN INC.,2011,fourth_quarter,PHA,Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program.,"Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID)",30000,,0,0,2012-01-18T15:56:04-05:00
1191974,e301d61f-ff7a-4585-bea1-9e83dad79049,Q4,AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS,1672,AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS,2011,fourth_quarter,PHA,"the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507)
the Stop Oxy Abuse Act of 2011 (H.R. 1316)
the Ryan Creedon Act of 2011 (H.R. 2119)","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE",,28611,0,0,2012-01-18T16:02:31-05:00
1192029,90000c3f-d217-43b9-832c-2524787cba5c,Q4,AMERICAN ADVERTISING FEDERATION,1411,AMERICAN ADVERTISING FEDERATION,2011,fourth_quarter,PHA,"Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals
Proposals to require a moratorium on the advertising of new prescription medicines
Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications
HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,41000,0,0,2012-01-18T16:11:52-05:00
1192074,3f75f1fe-f653-473f-8ba4-7e2c1c72c51c,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"POZEN, INC.",2011,fourth_quarter,PHA,To provide incentives for new drug development.  No specific bills pending.,"HOUSE OF REPRESENTATIVES,SENATE",36000,,0,0,2012-01-18T16:20:16-05:00
1192448,7d09105d-f8a9-420e-b0d6-d301ccf41583,Q4,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2011,fourth_quarter,PHA,"Increased appropriations for systems to shorten the time between development of a drug and its release to the public
FDA reform as it relates to drug development and research
Collaborative research on drug development                                 anti-malarial pharmaceuticals
FY 2011 Agricultural Appropriations                                             human factors research related to neuropharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,88684,0,0,2012-01-18T17:12:52-05:00
1193418,f626520b-03e3-49c4-b6fd-4dec71693e38,Q4,SQUIRE PATTON BOGGS,30906,KV PHARMACEUTICAL COMPANY,2011,fourth_quarter,PHA,Issues regarding Medicaid coverage of Makena and regulatory treatment of Makena.,"HOUSE OF REPRESENTATIVES,SENATE",230000,,0,0,2012-01-19T07:57:53-05:00
1194040,60a6a386-1608-41f6-8f9f-877aa3905da3,Q4,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2011,fourth_quarter,PHA,"Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions.  Legislation of interest includes the America Invents Act of 2011 (H.R. 1249).","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-19T10:16:10-05:00
1194247,decbf581-f532-4069-bb4b-5e86175e6ffc,Q4,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2011,fourth_quarter,PHA,"S.27, Preserve Access to Affordable Generics Act
S.31, Prescription Drug and Health Improvement Act of 2011
S.319, Pharmaceutical Market Access and Drug Safety Act of 2011
H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs
H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011
H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011
S.1058, Pharmacy Competition and Consumer Act of 2011
S.1356, Affordable Medicines Utilization Act of 2011
S.1584, Drug Safety and Accountability Act of 2011
H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011
S.2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE",,380000,0,0,2012-01-19T10:41:42-05:00
1195165,26c9ed76-98a4-4b96-b3c5-fec969b1f9d6,4T,"THE RUSSELL GROUP, INC.",22688,GENERIC PHARMACEUTICAL ASSOCIATION,2011,fourth_quarter,PHA,"Issues relative to generic pharmaceuticals and generic biologics; FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",50000,,0,1,2012-01-19T12:27:20-05:00
1195285,64a03caa-94ce-464d-9575-af3fc9f33a40,Q4,"OMNICARE, INC.",321112,OMNICARE INC,2011,fourth_quarter,PHA,Advocacy in support of S1560 promoting changes to Controlled Substances Act providing access to pain medication for nursing home residents.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,140000,0,0,2012-01-19T12:45:07-05:00
1195351,4ff12899-c02d-444b-a702-159c02e900ec,Q4,EISAI INC.,400321512,EISAI INC.,2011,fourth_quarter,PHA,"Prescription Drug User Fee Act reauthorization.
FDA-DEA issues.
Drug shortages issues.","HOUSE OF REPRESENTATIVES,SENATE",,750000,0,0,2012-01-19T12:54:34-05:00
1195497,d5997c0e-aa0f-4ede-b9e7-55e69978081c,Q4,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2011,fourth_quarter,PHA,"H.R. 979, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2011, legislation to reform oversight authority for OPM for the FEHBP drug benefit; SEE ADDENDUM H.R. 891 and S. 274, the Medication Therapy Management Benefits Act of 2011;  H.R. 1041, the Fairness in Medicare Bidding Act, this legislation would repeal the competitive bidding program, in the Medicare Part B durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) program;  S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011;  H.R. 1936, the Medicare Access to Diabetes Act of 2011;  H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011;  HR. 1409, the Quality Health Care Coalition Act of 2011;  H.R. 1839, the Community Pharmacy Fairness Act;  S. 1560, Nursing Home Resident Pain Relief Act of 2011;  S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program;  Sought Congressional support for the FTC investigation of the merger between two major national PBMs;  H.R. 1540 and S. 1253, the National Defense Authorization Act for FY 12;  H.R. 1316, the Pill Mill Crackdown Act of 2011;  S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011;  S. 513, Saving Kids from Dangerous Drugs Act of 2011;  H.R. 2939, Pharmaceutical Stewardship Act of 2011;  H.R. 866, the National All Schedules Prescription Electronic Reporting Act (NASPER) Reauthorization Act of 2011;  S. 1356, Affordable Medicines Utilization Act of 2011;  S. 296, Preserving Access to Life-Savings Medications Act;  H.R. 2245, Preserving Access to Life-Savings;  Medications Act of 2011;  S. 1699, Prescription Drug Cost Reduction Act;  S. 1867, National Defense Authorization Act for 2012;  S. 2002, Online Pharmacy Safety Act;  S. 1251, Medicare and Medicaid FAST Act;  S. 882, STOP Act;  S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011;  S. 1002, SAFE Doses Act;  The Joint Select Committee on Deficit Reduction","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE",,189480,0,0,2012-01-19T13:10:28-05:00
1195514,536c456c-d184-44a4-9b85-99d386b35335,Q4,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,29403,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2011,fourth_quarter,PHA,"Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA H.R. 1483 - Drug Safety Enhancement Act of 2011.  Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections.

S. 1584 - Drug Safety and Accountability Act of 2011.  Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand registration requirements for drug manufacturers, wholesalers, distributors, and retailers; grants FDA mandatory recall authority; requires adequate documentation of the pharmaceutical supply chain; all sections.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,180000,0,0,2012-01-19T13:12:34-05:00
1195589,ee7c85ff-e6ac-4dd0-91d7-1705899e31a7,Q4,LOCKE LORD PUBLIC POLICY GROUP LLC,300971,MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES,2011,fourth_quarter,PHA,Pharmaceutical performance reimbursement; biogenics,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-19T13:16:52-05:00
1195829,b706d751-d004-4bb2-99df-fcc027c2719f,Q4,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION,31348,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION,2011,fourth_quarter,PHA,"H.R. 1409:  All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274:  All provisions of the Medication Therapy Management Benefits Act of 2011;  H.R. 905 /S. 733:All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; H.R. 979All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

H.R. 605 / S. 312All provisions of the Patients Freedom to Choose Act 

S. 27            All provisions of the Preserve Access to Affordable Generics Act 

S. 31All provisions of the Prescription Drug and Health Improvement Act of 2011

S. 44All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011

H.R. 999 / S. 560All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011

H.R. 1839                              All provisions of the Community Pharmacy Fairness Act of 2011;

H.R. 1946                              All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011;

H.R. 1971 / S. 1058             All provisions of the Pharmacy Competition and Consumer Choice Act of 2011

Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap

Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio)

Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors

Implementation of changes to the definition of Average Manufacturer Price in Medicaid

Issues related to the management of Medicaid prescription drug benefits

Legislation to promote generic drugs

FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of approval pathway for generic biologic drugs

340b program

H.R. 2672  the Preserving Access to Orphan Drugs Act

H.R. 2182  the Generating Antibiotic Incentives Now Act

H.R. 3026  the Safeguarding Americas Pharmaceuticals Act

H.R. 2746  the Cancer Drug Coverage Parity Act","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE",,446695,0,0,2012-01-19T13:39:43-05:00
1196072,9ae6d1a2-1c7c-41f8-a424-1bc9a3f9a356,Q4,HANCE SCARBOROUGH,17443,INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION),2011,fourth_quarter,PHA,Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-01-19T14:02:24-05:00
1196145,f9725814-bdb4-4dcd-a9dc-700c2680be90,Q4,"GENENTECH, INC",15920,GENENTECH INC,2011,fourth_quarter,PHA,Monitor drug safety; payment policies for prescription drugs; Prescription Drug User Free Act; advocacy related to ensuring access to necessary medicines,"HOUSE OF REPRESENTATIVES,SENATE",,1256000,0,0,2012-01-19T14:08:10-05:00
1196174,be7d4568-a5db-4879-a696-02606e7bfb84,Q4,340B HEALTH,316434,340B HEALTH,2011,fourth_quarter,PHA,Advocating for the passage of H.R. 2674.  Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity.  Ensuring adequate reimbursement to 340B covered entities from third party payers.  Reversing 340B orphan drug discount prohibition for certain covered entities.,"Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",,228296,0,0,2012-01-19T14:11:04-05:00
1196238,e376b7ca-0c6e-4f05-a342-b858ba7c872b,Q4,HANCE SCARBOROUGH,17443,TEXAS ACADEMY OF COMPOUNDING PHARMACISTS,2011,fourth_quarter,PHA,Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-01-19T14:16:29-05:00
1196291,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,PHA,"Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012.
Counterfeit drug penalty enforcement act - S 1886, Counterfeit Drug Penalty Enhancement Act of 2011.
Patent and generic drugs - Congressional investigation re this issue.","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00
1196489,c40a5f6e-1352-4ae8-9f21-2f6f4bc61483,Q4,GREATER NEW YORK HOSPITAL ASSOCIATION,16830,GREATER NEW YORK HOSPITAL ASSOCIATION,2011,fourth_quarter,PHA,"Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations.","Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,260000,0,0,2012-01-19T14:41:23-05:00
1196697,e632aba7-02aa-46ca-8911-18a76d706b02,Q4,AARP,1694,AARP,2011,fourth_quarter,PHA,"Consolidated Appropriations Act, FY 2012, H.R. 2055, H.R. 3671, H.R. 2017, Consolidated and Further Appropriations Continuing Appropriations Act, H.R. 2112, Continuing Resolution, FY 2012, H.R. 2608 and H.J. Res.79, 94 and 95 - Lobbied for funding for agencies and programs within jurisdiction of the Agriculture Appropriations bill ( H.R. 2112, S. 1573), including funding for the FDA Office of Generic Drugs.
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill)
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)
Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill)
Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill)
Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill)
Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill)
Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs.
Discussed greater affordability of generic versions of both generic and biologic drugs.
S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad.
S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries.
H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications.
S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies.
Discussed counterfeit drug penalty enhancement (S. 1886/H.R.3468).","Administration on Aging,Agriculture, Dept of (USDA),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Energy Regulatory Commission (FERC),Federal Highway Administration (FHA),Federal Reserve System,Federal Trade Commission (FTC),Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Highway Traffic Safety Administration (NHTSA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office",,2740000,0,0,2012-01-19T14:56:19-05:00
1197091,003c9f29-5098-4880-9f47-8dd172591062,Q4,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2011,fourth_quarter,PHA,Hospital Discounts (HR 3590),"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR),White House Office",,2945000,0,0,2012-01-19T15:22:46-05:00
1197155,ee93fa3d-4cb0-43d0-984b-569e2c3114ae,Q4,"WHITMER & WORRALL, LLC",292892,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2011,fourth_quarter,PHA,Issues related to monitoring healthcare reform.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-01-19T15:27:16-05:00
1197926,338e0d0a-e3ee-4575-a538-7c4ebee5b911,Q4,CVS HEALTH (AND SUBSIDIARIES),302778,CVS CAREMARK INC,2011,fourth_quarter,PHA,Issues related to drug safety and the drug supply chain.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,2845000,0,0,2012-01-19T16:16:04-05:00
1197960,ce7947b8-b07a-4397-b09f-f8b1b3499062,Q4,BLUECROSS BLUESHIELD OF TENNESSEE,6440,BLUECROSS BLUESHIELD OF TENNESSEE,2011,fourth_quarter,PHA,General Pharmacy Issues,"HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2012-01-19T16:17:18-05:00
1197961,f2001d1a-6f04-42f8-9374-d7df0a3c25e7,Q4,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,340B HEALTH,2011,fourth_quarter,PHA,"Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of ""patient"" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Veterans Affairs, Dept of (VA)",40000,,0,0,2012-01-19T16:17:19-05:00
1198128,fcf2f802-9fa6-4835-a0c1-65136dc6a75a,Q4,"AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)",1581,AMERICA'S HEALTH INSURANCE PLANS INC (AHIP),2011,fourth_quarter,PHA,"H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch)  FEHBP prescription drugs, 
H.R.1946, Preserving Hometown Independent Pharmacies Act (Marino)  antitrust exemption for independent pharmacies, 
S. 27, Preserve Access to Affordable Generics Act (Kohl)  pay-for-delay settlements. 16.  Specific Lobbying Issues (con't):
PHA (Regulatory Issues):
Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; and issues relating to access for investigational drugs.","Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Personnel Management (OPM),Pension & Welfare Benefits Administration,SENATE,Social Security Administration (SSA),Treasury, Dept of,White House Office",,2750000,0,0,2012-01-19T16:28:24-05:00
1198324,f2467268-2e01-463f-9cef-c3bf8c04133d,Q4,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2011,fourth_quarter,PHA,"H.R. 2245, S 296
Supportive of language that increases access to life saving medications.","HOUSE OF REPRESENTATIVES,SENATE",,33514,0,0,2012-01-19T16:44:43-05:00
1198379,64cfe3f1-b177-47ad-8921-5d288114a822,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2011,fourth_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of ""dispense"" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice.  No specific legislation yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-01-19T16:49:06-05:00
1198576,301c446a-44bc-4561-8c8c-57188974aa55,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2011,fourth_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2012-01-19T17:02:33-05:00
1198644,79cf9302-482c-4cb5-8ff6-769d817c8464,Q4,"PODESTA GROUP, INC.",31680,EISAI INC.,2011,fourth_quarter,PHA,"Drug issues.
Prescription Drug User Fee Act reauthorization.
FDA-DEA issues.
Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012,  Pub. L. 112-055.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-19T17:10:05-05:00
1198715,8e5c8830-1d45-4950-9c2b-7409f09e9ddc,Q4,EMPIRE CONSULTING GROUP,400703105,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2011,fourth_quarter,PHA,Proposals relating to Medicare Part D; Super Committee deficit reduction proposals; and drug shortages.,HOUSE OF REPRESENTATIVES,30000,,0,0,2012-01-19T17:18:34-05:00
1198736,bdac9769-5487-4ec1-80ac-c330ca48c24f,Q4,"TARPLIN, DOWNS & YOUNG, LLC",304736,ASTRAZENECA,2011,fourth_quarter,PHA,"**see addendum page Prescription drug importation
     S. 319  Pharmaceutical Market Access and Drug Safety Act of 2011
     H.R. 147 - Prescription Drug Affordability Act
     H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act

***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-19T17:19:40-05:00
1198767,6a2fe86f-285e-42f5-93bc-a594831af987,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2011,fourth_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-01-19T17:21:50-05:00
1198859,b5284c51-daa3-43e1-b469-d410e9809f7b,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2011,fourth_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.

Proposals to amend the Controlled Substances Act to clarify the definition of ""dispense"" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice.  No specific legislation yet.

Regulatory issues involving compounded 17P and compounded Avastin.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-01-19T17:30:28-05:00
1198868,a90948c5-8533-474f-a982-70beda5de486,Q4,"TARPLIN, DOWNS & YOUNG, LLC",304736,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2011,fourth_quarter,PHA,"**see addendum page Prescription drug importation
     S. 319  Pharmaceutical Market Access and Drug Safety Act of 2011
     H.R. 147 - Prescription Drug Affordability Act
     S. 296 - Drug Shortage Act
     H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012, drug importation
     
***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2012-01-19T17:31:31-05:00
1198963,f6b3de2d-a153-48d0-b8c5-0dd9cc131654,Q4,"TARPLIN, DOWNS & YOUNG, LLC",304736,PHRMA,2011,fourth_quarter,PHA,"**see addendum page Prescription drug importation
     S. 319  Pharmaceutical Market Access and Drug Safety Act of 2011
     H.R. 147 - Prescription Drug Affordability Act
     H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012, drug importation


***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2012-01-19T17:38:09-05:00
1198971,b9c0b64f-aa71-4e3a-9794-09bde6cd3f29,Q4,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2011,fourth_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.

Proposals to amend the Controlled Substances Act to clarify the definition of ""dispense"" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice.  No specific legislation yet.

Regulatory issues involving compounded 17P.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-01-19T17:39:13-05:00
1199500,22082746-1d9d-4107-9011-b8fc21ff8b88,Q4,"C2 GROUP, LLC",66693,PERRIGO INC,2011,fourth_quarter,PHA,"OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-19T18:41:03.627000-05:00
1199739,c7863ce6-f326-41ad-a272-893a51b513c9,Q4,THE UNITED STATES PHARMACOPEIAL CONVENTION,400358632,THE UNITED STATES PHARMACOPEIAL CONVENTION,2011,fourth_quarter,PHA,"- Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients.
- Implementation of the Food Safety Modernization Act.
- Issues regarding creating and updating monographs. - Issues regarding FDA funding.
- S 1584, ""Drug Safety Accountability Act of 2011"", regarding advice on drug quality.
- HR 1483, ""Drug Safety Enhancement Act of 2011"", regarding advice on drug quality.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)",,60000,0,0,2012-01-19T19:10:32.827000-05:00
1199909,5dd6ed72-6ca0-4b16-b5ea-a2f685f0d3e5,Q4,AKIN GUMP STRAUSS HAUER & FELD,682,"PRASCO, INC.",2011,fourth_quarter,PHA,Promoting consumer benefits of authorized generic drugs,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-01-19T19:37:48.203000-05:00
1200028,3a9ac99b-cd64-481c-80aa-48ed94ec0ef7,Q4,DLA PIPER LLP (US),76855,SANOFI PASTEUR,2011,fourth_quarter,PHA,"Pandemic influenza, vaccine-related issues; H.Res. 295, promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.","HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE",40000,,0,0,2012-01-19T20:19:40.733000-05:00
1200105,49f88942-9ff4-4039-96d4-dfa051e583cb,Q4,STEVE BUYER GROUP,400701097,OMNICARE,2011,fourth_quarter,PHA,Advocacy in support of S1560 promoting changes to Controlled Substances Act providing access to pain medication for nursing home residents.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-19T21:01:12.480000-05:00
1200367,c3bb45a5-3dd3-49d3-8094-075f6ce80149,Q4,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2011,fourth_quarter,PHA,"FDA salaries and expenses; and extramural research related issues:
   H.R.2112,Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012
   Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011
   Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012","Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-20T05:09:36.423000-05:00
1200372,3945891f-06c7-4f0e-bea6-a982af82c4cd,Q4,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2011,fourth_quarter,PHA,No lobbying activity.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-20T05:11:38.003000-05:00
1200382,582f9b09-dd79-4fa8-9ddf-8ec52d9bfb72,Q4,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2011,fourth_quarter,PHA,"FDA funding initiatives; Critical Path Partnership.
  H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012
  Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011
  Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-01-20T05:12:39.270000-05:00
1200524,ba92b078-7a91-45c3-b1c1-cf46454b4a0f,Q4,MCDERMOTT WILL & SCHULTE LLP,24338,"ALLERGAN, INC.",2011,fourth_quarter,PHA,Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-01-20T07:53:29.500000-05:00
1200625,8dd17a6d-a424-44da-9f3e-ff6b7ab2edcd,Q4,"COMPASS CONSULTING GROUP, LLC",295031,"AMYLIN PHARMACEUTICALS, INC.",2011,fourth_quarter,PHA,"General FDA, pharmaceutical, and Medicare issues.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-01-20T08:44:08.983000-05:00
1200628,c0ce4c81-7d17-4380-999d-5c5cb4b3937a,Q4,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2011,fourth_quarter,PHA,Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",240000,,0,0,2012-01-20T08:46:10.470000-05:00
1201004,0807f591-185a-4522-8a1a-9ce35daea4c0,Q4,SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP),55223,COVERMYMEDS,2011,fourth_quarter,PHA,Prescription drug prior authorizations and other insurance coverage determinations.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS)",10000,,0,0,2012-01-20T09:32:21.593000-05:00
1201438,adaa0f90-630e-4c98-ae6d-90f853542cb3,Q4,"CARDINAL HEALTH, INC.",58055,CARDINAL HEALTH INC,2011,fourth_quarter,PHA,Advocacy on reducing prescription drug abuse.,"HOUSE OF REPRESENTATIVES,SENATE",,235000,0,0,2012-01-20T10:02:00.560000-05:00